Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2006 2
2007 1
2008 4
2009 4
2010 2
2011 4
2012 4
2013 1
2014 3
2015 1
2016 4
2017 4
2018 3
2019 2
2020 5
2021 6
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for peter von zur muhlen
Search for Peter Von zur Muehlen instead (2 results)
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flügel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Möllmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schühlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tölg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A; ISAR-REACT 5 Trial Investigators. Schüpke S, et al. N Engl J Med. 2019 Oct 17;381(16):1524-1534. doi: 10.1056/NEJMoa1908973. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475799 Clinical Trial.
A comparative gene expression matrix in Apoe-deficient mice identifies unique and atherosclerotic disease stage-specific gene regulation patterns in monocytes and macrophages.
Härdtner C, Kumar A, Ehlert CA, Vico TA, Starz C, von Ehr A, Krebs K, Dufner B, Hoppe N, Stachon P, Heidt T, Wolf D, von Zur Mühlen C, Grüning B, Robbins CS, Maegdefessel L, Westermann D, Dederichs TS, Hilgendorf I. Härdtner C, et al. Atherosclerosis. 2023 Apr;371:1-13. doi: 10.1016/j.atherosclerosis.2023.03.006. Epub 2023 Mar 15. Atherosclerosis. 2023. PMID: 36940535 Free article.
P2X4 deficiency reduces atherosclerosis and plaque inflammation in mice.
Peikert A, König S, Suchanek D, Rofa K, Schäfer I, Dimanski D, Karnbrock L, Bulatova K, Engelmann J, Hoppe N, Wadle C, Heidt T, Albrecht P, von Garlen S, Härdtner C, Hilgendorf I, Wolf D, von Zur Mühlen C, Bode C, Zirlik A, Duerschmied D, Merz J, Stachon P. Peikert A, et al. Sci Rep. 2022 Feb 18;12(1):2801. doi: 10.1038/s41598-022-06706-6. Sci Rep. 2022. PMID: 35181718 Free PMC article.
Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile.
Merz J, Nettesheim A, von Garlen S, Albrecht P, Saller BS, Engelmann J, Hertle L, Schäfer I, Dimanski D, König S, Karnbrock L, Bulatova K, Peikert A, Hoppe N, Hilgendorf I, von Zur Mühlen C, Wolf D, Groß O, Bode C, Zirlik A, Stachon P. Merz J, et al. Purinergic Signal. 2021 Sep;17(3):481-492. doi: 10.1007/s11302-021-09798-3. Epub 2021 Jul 20. Purinergic Signal. 2021. PMID: 34282551 Free PMC article.
Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering.
Härdtner C, Kornemann J, Krebs K, Ehlert CA, Jander A, Zou J, Starz C, Rauterberg S, Sharipova D, Dufner B, Hoppe N, Dederichs TS, Willecke F, Stachon P, Heidt T, Wolf D, von Zur Mühlen C, Madl J, Kohl P, Kaeser R, Boettler T, Pieterman EJ, Princen HMG, Ho-Tin-Noé B, Swirski FK, Robbins CS, Bode C, Zirlik A, Hilgendorf I. Härdtner C, et al. Basic Res Cardiol. 2020 Dec 9;115(6):78. doi: 10.1007/s00395-020-00838-4. Basic Res Cardiol. 2020. PMID: 33296022 Free PMC article.
48 results